학술논문

Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: Analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study
Document Type
Article
Source
In: Chest. (Chest, April 2013, 143(4):955-962)
Subject
Language
English
ISSN
19313543
00123692